On Wednesday, the Boston-based startup announced it raised $6.7 million in a Series A funding round led by F-Prime Capital Partners, a Cambridge, MA-based venture capital firm affiliated with Fidelity Investments. Other investors in the round include New York-based FundRx and individual investors. Le says Buoy has now raised a total of $9.2 million from investors. The company sits at the intersection of several trends, including the proliferation of software tools geared toward helping patients be more proactive in their care, and a push to apply artificial intelligence-related technologies to healthcare.

Hamburg-based online logistics pricing start-up Cargonexx is expanding rapidly across Europe. It was founded in 2016 by Rolf-Dieter Lafrenz and Andreas Karanas and its business model is based on big data, artificial intelligence and one-click trading of loads. The objective of Cargonexx is to offer a solution to dead-head mileage and thereby support the reduction of fuel consumption and CO2 emissions.

Neurotechnology startup Rythm is building Morpheo, an open-source and secure initiative to help develop machine learning models for automatic and predictive diagnosis of sleep disorders.Morpheo will explore and provide sleep clinicians with a free online software that will automatically analyze sleep patterns and help improve and speed diagnosis related to sleep.

International logistics company launches AI-enabled chatbot on Facebook Messenger

Bengaluru startup Artelus offers advanced screening tools to enable burdened healthcare professionals to service the increasing patient load with accurate diagnosis and preventative care.

Microsoft is making use of artificial intelligence to advance healthcare in India. Redmond is teaming up with the state of Telangana in India where the company will be using its artificial intelligence technology to provide healthcare for children with eye problems.

It’s not unforeseen for companies to embrace the digital age these days, but very seldom do they do it with the all-encompassing approach we’ve seen from JD.com in recent weeks and months.

Startup company Viome announced today that it has raised $15 million in Series A funding to support the launch of its at-home human microbiome testing kit. Viome’s testing kit uses meta-transcriptome sequencing technology to identify and assess gut microorganisms, and analyzes their behaviors. The technology specifically targets bacteria, viruses, yeast, fungus, and mold in the system, the company said. By applying machine learning to the analysis, Viome then creates personalized recommendations to balance the gut microbiome.

Bangalore-based Touchkin eServices Pvt. Ltd, which operates predictive health-tech startup Touchkin, has raised $1.3 million (Rs 8.33 crore) from early-stage investment firm Kae Capital and a clutch of other investors. The company’s indigenously built machine learning platform collects user data from mobile phones to track several aspects of a user’s daily life, including activity, communication and sleep patterns. It then analyses this data to identify important lifestyle or behavioural changes that could have a health implication.

The formal application process will start in September. Part of a “personalized” program in Fairfax, the offer is $75,000 for 10 percent equity, plus access to one of Virginia’s biggest health systems. What kind of companies will fit into the “personalized health” and “precision medicine” categories? It’s a big range, from predictive analytics, artificial intelligence, big data, wearable devices to newer corners still. For now, Inova wants to hear what you got.